Globeflex Capital’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.12K Buy
+36
New +$2.2K ﹤0.01% 377
2020
Q3
– Sell
-24,486
Closed -$500K – 522
2020
Q2
$500K Buy
+24,486
New +$390K 0.13% 269
2016
Q1
– Sell
-21,400
Closed -$413K – 496
2015
Q4
$413K Hold
21,400
– – 0.11% 252
2015
Q3
$434K Buy
+21,400
New +$634K 0.09% 298

Other funds holding TVTX

Globeflex Capital's TVTX Position: Q3 2026 in Review

Globeflex Capital opened a new position in Travere Therapeutics (TVTX) in Q3 2026: 36 shares worth $2.12K. The stake represents ﹤0.01% of the portfolio and ranks #377 among its holdings. This is a return to the name: Globeflex Capital previously reported a position in TVTX as recently as Q2 2020.

Globeflex Capital first reported a position in TVTX in Q3 2015 and has held it in 4 quarters since. The position peaked at $500K in Q2 2020. 345 funds tracked by Wall St. Rank hold TVTX as of Q3 2026.

  • Globeflex Capital held 36 shares of Travere Therapeutics worth $2.12K as of Q3 2026.
  • Travere Therapeutics was a new Globeflex Capital position in Q3 2026.
  • Travere Therapeutics made up ﹤0.01% of Globeflex Capital's portfolio in Q3 2026, its #377 holding.
  • Globeflex Capital first reported a position in Travere Therapeutics in Q3 2015 and has held it in 4 quarters since.
  • Globeflex Capital's Travere Therapeutics position peaked at $500K in Q2 2020.
  • 345 funds tracked by Wall St. Rank held Travere Therapeutics as of Q3 2026.

Based on Globeflex Capital's 13F filing for Q3 2026, filed 16 Nov 2026.